Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith A Gilbert

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
The Lancet. Oncology|May 9, 2014
Idelalisib: targeting PI3Kδ in B-cell malignanciesJudith A Gilbert
The Lancet. Oncology|October 2, 2012
Potential therapeutic target for triple-negative breast cancerJudith A Gilbert
The Lancet. Oncology|September 24, 2013
Lenalidomide as first-line therapy for elderly CLL patientsJudith A Gilbert
The Lancet. Oncology|July 4, 2017
Savolitinib for MET-driven papillary renal cell carcinomaJudith A Gilbert
The Lancet. Respiratory Medicine|August 21, 2014
Reducing complications from obstructive sleep apnoeaJudith A Gilbert
The Lancet. Oncology|January 26, 2016
Reducing treatment-related mortality in childhood cancersJudith A Gilbert
The Lancet. Oncology|February 3, 2016
Prediction of chemotherapy benefit for colon cancersJudith A Gilbert
The Lancet. Oncology|March 22, 2016
Reduced intensity transplantation in follicular lymphomaJudith A Gilbert
The Lancet. Oncology|August 29, 2017
Pazopanib for advanced liposarcomaJudith A Gilbert
The Lancet. Oncology|October 21, 2014
Adapted paediatric regimen benefits adults with ALLJudith A Gilbert
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
The Lancet. Oncology|May 9, 2014
Idelalisib: targeting PI3Kδ in B-cell malignanciesJudith A Gilbert
The Lancet. Oncology|October 2, 2012
Potential therapeutic target for triple-negative breast cancerJudith A Gilbert
The Lancet. Oncology|September 24, 2013
Lenalidomide as first-line therapy for elderly CLL patientsJudith A Gilbert
The Lancet. Oncology|July 4, 2017
Savolitinib for MET-driven papillary renal cell carcinomaJudith A Gilbert
The Lancet. Respiratory Medicine|August 21, 2014
Reducing complications from obstructive sleep apnoeaJudith A Gilbert
The Lancet. Oncology|January 26, 2016
Reducing treatment-related mortality in childhood cancersJudith A Gilbert
The Lancet. Oncology|February 3, 2016
Prediction of chemotherapy benefit for colon cancersJudith A Gilbert
The Lancet. Oncology|March 22, 2016
Reduced intensity transplantation in follicular lymphomaJudith A Gilbert
The Lancet. Oncology|August 29, 2017
Pazopanib for advanced liposarcomaJudith A Gilbert
The Lancet. Oncology|October 21, 2014
Adapted paediatric regimen benefits adults with ALLJudith A Gilbert
Pageof 5